Science & Finance: The Biotech Blend
Financial leaders from clinical-stage biopharma gather to discuss the critical role of finance and accounting (F&A) in supporting and sustaining the science at the forefront of engagement with investors.
Europe’s Digital Health Path Still at a Crossroads
The Commission’s gestures toward enacting formal standards to digitize health records are masking wider policy gaps.
Lessons for Pharma from the Merck Cyber Attack
Almost a year and a half later, key understandings have emerged to help companies better combat future data-breach attempts.
Securing a Winning Strategy for Real-World Evidence
While the increasing importance of real-world evidence (RWE) is widely acknowledged, the dramatic shift required by pharma to embed meaningful and holistic benefits from this capability is still a work in progress.
RWE: Answering Questions in Rare Disease
Sonalee Agarwal, head of value and evidence strategy for Alnylam, talks with Pharm Exec about the role of real-world evidence in the rare and ultra-rare disease space.
Can New Tech Outsmart Status Quo?
In pharma, there may be hope that companies' and the industry's ability to adapt to change may finally be catching up to the pace of new and intelligent uses of technology and clinical data.
Measuring the Probability of Pricing and Access Success
There is still no structured method of assessing pricing and access risk for drug manufacturers. Presented here is a straightforward measure for
integrating pricing and access risk into portfolio planning and decision-making.
Four Challenges for AI in the Life Sciences
Objective considerations when gauging investment.
Pharmaceutical Executive, December 2018 Issue (PDF)
Click the title above to open the Pharmaceutical December 2018 issue in an interactive PDF format.
Country Report: Malaysia
With a reputation as a reliable, if somewhat unspectacular, marketplace, Malaysia has long appealed to life science investors lured in by the prospect of generating consistent returns.
Attack Mounts on Biopharma Drug Prices
Efforts intensify to bring outlays more in line with global trends.
2 Commerce Drive Cranbury, NJ 08512